NextGen Sciences has entered default in a suit filed by six former employees alleging that the company and its officers Leif Hamoe and Thomas Borcholte failed to pay them wages owed for the period Aug. 1, 2012, through Oct.
NextGen Group has announced that due to an inability to secure additional financing it will likely take steps to wind down its business unless it is able in the near future to find a buyer for its principal subsidiary, protein biomarker firm NextGen Sciences.
A research team led by scientists at Boston University has identified several RNA-binding proteins as potential therapeutic targets and biomarkers for neurodegenerative diseases including Alzheimer's.
NextGen Sciences this week launched its CSFassay-rat A.1.0 assay for the discovery and quantification in rats of protein biomarkers linked to central nervous system disorders including dementia and Parkinson's.
NextGen Sciences this week introduced its PLASMAssay-human A.1.0 protein biomarker discovery panel.
The panel uses selected-reaction monitoring mass spectrometry to simultaneously measure levels of 52 plasma proteins.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – UK-based NextGen Group announced this week it has completed the formation of a diagnostics subsidiary to develop tests for central nervous system disorders.
NextGen Sciences this week launched its csfdiscovery 82 multiplex protein assay for the discovery and quantification of protein biomarkers linked to central nervous system diseases including Alzheimer's, Parkinson's, and multiple sclerosis.
A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.
